NPPA revises the ceiling prices of eight scheduled drugs to meet the twin objectives of availability and affordability
Image used for representation purpose only. The National Pharmaceutical Pricing Authority (NPPA) has approved an increase in the ceiling prices of eleven scheduled formulations of eight drugs by 50% of their current ceiling prices. Most of these drugs are low-cost and generally used as first line treatment crucial to the public health programmes of the…